Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you consider eliminating post lumpectomy RT in a premenopausal patient with pCR after chemotherapy for a cT1cN0 triple negative breast cancer?
Answer from: Radiation Oncologist at Community Practice
We don't have any prospective data on omitting RT in this case and would not consider this approach for triple negative patients.
Sign In
or
Register
to read more
12900
Related Questions
How would you approach the treatment of low grade, stage IA, triple negative apocrine adenocarcinoma of the breast in a female patient in her 70s?
How do you approach reirradiation in a patient who underwent breast-conserving surgery for recurrent breast cancer after initial lumpectomy and APBI?
For a patient who previously underwent PBI and then developed a second ipsilateral primary, would you offer repeat PBI?
How do you approach breast hypofractionation RNI with the results of the Skagen Trial 1?
What are your top takeaways in Radiation Oncology from SABCS 2025?
Is it appropriate to use bolus with hypofractionated PMRT?
Is there additional concern for late cardiac toxicity when using ultrahypofractionated breast radiation protocols, given that the BED to the heart is higher?
Does micropapillary subtype for a G1-2 DCIS affect your radiation treatment recommendations?
Would you offer PMRT to a patient with pTisN1a left breast DCIS?
How would you manage an isolated nodal recurrence of breast cancer in a patient with a prior history of mantle-field radiation?